News

Spin-Offs

Ligand Pharmaceuticals To Spin Off Antibody Discovery Business Via SPAC Merger

Edward Kim | Equities.com |

Shareholders of Ligand will receive 100% of OmniAb in a tax-free distribution


Sponsored Financial Content

Market Movers